Gota
Sinopsis
La gota es una forma de artritis inflamatoria causada por la acumulación de cristales de ácido úrico en las articulaciones, lo que lleva a episodios repentinos y graves de dolor, hinchazón, enrojecimiento y sensibilidad—más comúnmente en el dedo gordo del pie, aunque puede afectar los tobillos, las rodillas, los dedos de las manos o los codos. Estos episodios se conocen como ataques de gota y pueden durar días o semanas.
La gota se desarrolla cuando los niveles de ácido úrico en la sangre se vuelven demasiado altos (hiperuricemia), generalmente debido a una producción excesiva o una excreción deficiente por parte de los riñones. El ácido úrico es un subproducto del metabolismo de las purinas (que se encuentran en la carne roja, los mariscos, el alcohol y algunas verduras). Cuando se cristaliza en las articulaciones, desencadena una intensa respuesta inmunitaria.
Factores de riesgo clave:
-
Dieta rica en purinas (vísceras, mariscos, alcohol, bebidas azucaradas)
-
Obesidad
-
Hipertensión o enfermedad renal
-
Ciertos medicamentos (diuréticos, aspirina en dosis bajas)
-
Genética
-
Deshidratación
Cuándo consultar a un médico:
Busque atención si experimenta dolor articular repentino, hinchazón o calor—especialmente si se repite. La gota es tratable con medicamentos para reducir los niveles de ácido úrico y disminuir la inflamación. La gota crónica puede dañar las articulaciones y causar depósitos visibles de urato (tofos).
Remedios Naturales
Ingredientes
- 5-Hidroxitriptófano (5-HTP)Científico
5-HTP has been investigated in narcolepsy as a serotonin precursor, given serotonin's role in modulating REM sleep and narcolepsy's association with REM sleep dysregulation. One clinical study found that 600 mg of 5-HTP improved nighttime sleep duration and restfulness in narcoleptics but did not reduce daytime sleep attacks. The neurobiological rationale stems from 5-HTP's conversion to serotonin, which is a precursor to melatonin and modulates REM sleep circuits.
- cafeínaCientífico
Caffeine has been used to manage excessive daytime sleepiness (EDS) in narcolepsy since at least 1925, making it among the earliest documented narcolepsy treatments. A 2020 double-blind, randomized, placebo-controlled pilot trial evaluated 200 mg caffeine daily as add-on therapy in narcolepsy patients, assessing drowsiness objectively and subjectively. Caffeine acts by blocking adenosine A1 and A2A receptors, promoting vigilance, but is less potent than prescription wakefulness agents.
- l-carnitineCientífico
L-carnitine has been studied specifically in narcolepsy due to observed abnormalities in fatty acid beta-oxidation and low acylcarnitine levels in narcolepsy patients. A 2013 randomized, double-blind, crossover, placebo-controlled trial in 30 narcolepsy patients (510 mg/day) found significant reduction in total daytime dozing time. A 2022 systematic review corroborated its efficacy and good tolerability at 500–510 mg/day, including during pregnancy.
- l-tirosinaCientífico
L-tyrosine, as a precursor to dopamine and norepinephrine, has been clinically studied in narcolepsy given the disorder's suspected dopaminergic underpinnings. An open case series (1987) reported freedom from sleep attacks and cataplexy in 8 patients within 6 months of oral tyrosine treatment. A subsequent 1989 Lancet double-blind, randomized, placebo-controlled crossover trial in 10 narcolepsy-cataplexy patients found a mild subjective stimulant effect (less tired, more alert) at 9 g/day but no clinically significant improvement in objective measures.
- MelatoninaCientífico
Melatonin, the pineal hormone regulating circadian sleep-wake cycles, is used in narcolepsy management primarily to improve disrupted nighttime sleep—a common comorbid symptom. Clinical literature indicates melatonin can slightly improve nighttime sleep consolidation in narcolepsy patients but does not address the core orexin deficiency, daytime sleep attacks, or cataplexy. Integrative medicine reviews cite melatonin as a supportive adjunct for narcolepsy's circadian and sleep fragmentation components.
- Tongkat aliCientífico
Tongkat Ali (Eurycoma longifolia) was investigated specifically in narcoleptic mice in a 2024 peer-reviewed study from Stanford University School of Medicine, published in SLEEP Advances. The study found that while Tongkat Ali supplementation enhanced sleep-wake consolidation and diurnal rhythms in wild-type mice, it did not sufficiently improve disturbed sleep-wake cycles or cataplexy in genetically narcoleptic mice. The research assessed its potential as a natural product for managing excessive daytime sleepiness in hypersomnia.